Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 758953733 | 7589537 | 33 | F | 20140507 | 20160921 | 20100916 | 20160927 | EXP | PHHY2010CA58863 | SANDOZ | 79.92 | YR | F | Y | 0.00000 | 20160927 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 758953733 | 7589537 | 1 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO (EVERY 4 WEEKS) | U | 0 | 20 | MG | VIAL | /month | |||||
| 758953733 | 7589537 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, QMO (EVERY 4 WEEKS) | U | S0049 | 0 | 40 | MG | VIAL | /month | ||||
| 758953733 | 7589537 | 3 | PS | METOPROLOL. | METOPROLOL | 1 | Unknown | 12.5 MG, QD | U | 73288 | 12.5 | MG | QD | ||||||
| 758953733 | 7589537 | 4 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | QD | ||||||
| 758953733 | 7589537 | 5 | C | DETROL | TOLTERODINE TARTRATE | 1 | Unknown | U | 0 | ||||||||||
| 758953733 | 7589537 | 6 | C | RABEPRAZOLE | RABEPRAZOLE | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 758953733 | 7589537 | 7 | C | LEVOCARB | CARBIDOPALEVODOPA | 1 | Unknown | U | 0 | ||||||||||
| 758953733 | 7589537 | 8 | C | ZOPICLONE | ZOPICLONE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 758953733 | 7589537 | 1 | Acromegaly |
| 758953733 | 7589537 | 3 | Product used for unknown indication |
| 758953733 | 7589537 | 4 | Product used for unknown indication |
| 758953733 | 7589537 | 5 | Product used for unknown indication |
| 758953733 | 7589537 | 6 | Product used for unknown indication |
| 758953733 | 7589537 | 7 | Product used for unknown indication |
| 758953733 | 7589537 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 758953733 | 7589537 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 758953733 | 7589537 | Alopecia | |
| 758953733 | 7589537 | Blood pressure increased | |
| 758953733 | 7589537 | Body temperature decreased | |
| 758953733 | 7589537 | Cerebrovascular accident | |
| 758953733 | 7589537 | Contusion | |
| 758953733 | 7589537 | Dizziness | |
| 758953733 | 7589537 | Dysarthria | |
| 758953733 | 7589537 | Fall | |
| 758953733 | 7589537 | Fatigue | |
| 758953733 | 7589537 | Headache | |
| 758953733 | 7589537 | Heart rate increased | |
| 758953733 | 7589537 | Hypotension | |
| 758953733 | 7589537 | Hypothyroidism | |
| 758953733 | 7589537 | Influenza | |
| 758953733 | 7589537 | Injection site haemorrhage | |
| 758953733 | 7589537 | Needle issue | |
| 758953733 | 7589537 | Presyncope | |
| 758953733 | 7589537 | Syncope | |
| 758953733 | 7589537 | Transient ischaemic attack |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 758953733 | 7589537 | 1 | 20100706 | 0 |